450 related articles for article (PubMed ID: 19747708)
41. Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells.
Danzy S; Studdard LR; Manicassamy B; Solorzano A; Marshall N; García-Sastre A; Steel J; Lowen AC
J Virol; 2014 Nov; 88(22):13436-46. PubMed ID: 25210184
[TBL] [Abstract][Full Text] [Related]
42. Atypical characteristics of nucleoprotein of pandemic influenza virus H1N1 and their roles in reassortment restriction.
Wanitchang A; Patarasirin P; Jengarn J; Jongkaewwattana A
Arch Virol; 2011 Jun; 156(6):1031-40. PubMed ID: 21340741
[TBL] [Abstract][Full Text] [Related]
43. Characterization of an avian influenza virus H5N1 Egyptian isolate.
Bahgat MM; Kutkat MA; Nasraa MH; Mostafa A; Webby R; Bahgat IM; Ali MA
J Virol Methods; 2009 Aug; 159(2):244-50. PubMed ID: 19406157
[TBL] [Abstract][Full Text] [Related]
44. Use of virulence index tests for avian influenza viruses.
Allan WH; Alexander DJ; Pomeroy BS; Parsons G
Avian Dis; 1977; 21(3):359-63. PubMed ID: 907578
[TBL] [Abstract][Full Text] [Related]
45. A multiplexed immunoassay for detection of antibodies against avian influenza virus.
Watson DS; Reddy SM; Brahmakshatriya V; Lupiani B
J Immunol Methods; 2009 Jan; 340(2):123-31. PubMed ID: 19000692
[TBL] [Abstract][Full Text] [Related]
46. Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine.
Anhlan D; Hrincius ER; Scholtissek C; Ludwig S
Vaccine; 2012 Jun; 30(30):4480-9. PubMed ID: 22575164
[TBL] [Abstract][Full Text] [Related]
47. Replication and pathogenesis associated with H5N1, H5N2, and H5N3 low-pathogenic avian influenza virus infection in chickens and ducks.
Mundt E; Gay L; Jones L; Saavedra G; Tompkins SM; Tripp RA
Arch Virol; 2009; 154(8):1241-8. PubMed ID: 19575275
[TBL] [Abstract][Full Text] [Related]
48. The pathogenicity of four avian influenza viruses for fowls, turkeys and ducks.
Alexander DJ; Allan WH; Parsons DG; Parsons G
Res Vet Sci; 1978 Mar; 24(2):242-7. PubMed ID: 653122
[TBL] [Abstract][Full Text] [Related]
49. Mutations in matrix protein 1 and nucleoprotein caused human-specific defects in nuclear exportation and viral assembly of an avian influenza H7N1 virus.
Ninpan K; Suptawiwat O; Boonarkart C; Songprakhon P; Puthavathana P; Auewarakul P
Virus Res; 2017 Jun; 238():49-62. PubMed ID: 28579356
[TBL] [Abstract][Full Text] [Related]
50. Australian surveillance for avian influenza viruses in wild birds between July 2005 and June 2007.
Haynes L; Arzey E; Bell C; Buchanan N; Burgess G; Cronan V; Dickason C; Field H; Gibbs S; Hansbro P; Hollingsworth T; Hurt A; Kirkland P; McCracken H; O'Connor J; Tracey J; Wallner J; Warner S; Woods R; Bunn C
Aust Vet J; 2009 Jul; 87(7):266-72. PubMed ID: 19573149
[TBL] [Abstract][Full Text] [Related]
51. Novel mutations in avian PA in combination with an adaptive mutation in PR8 NP exacerbate the virulence of PR8-derived recombinant influenza A viruses in mice.
Lee CY; An SH; Kim I; Choi JG; Lee YJ; Kim JH; Kwon HJ
Vet Microbiol; 2018 Jul; 221():114-121. PubMed ID: 29981696
[TBL] [Abstract][Full Text] [Related]
52. Influenza virus pathogenicity is determined by caspase cleavage motifs located in the viral proteins.
Zhirnov OP; Syrtzev VV
J Mol Genet Med; 2009 Jan; 3(1):124-32. PubMed ID: 19565021
[TBL] [Abstract][Full Text] [Related]
53. [Construction and immunogenicity of chimeric peptide antigen composed of M2e and NP genes of avian influenza virus].
Xu H; Hou H; Deng B; Zheng Q; Hou J
Wei Sheng Wu Xue Bao; 2009 Jun; 49(6):807-12. PubMed ID: 19673418
[TBL] [Abstract][Full Text] [Related]
54. Emergence of highly pathogenic virus during selective chicken passage of the prototype mildly pathogenic chicken/Pennsylvania/83 (H5N2) influenza virus.
Brugh M; Perdue ML
Avian Dis; 1991; 35(4):824-33. PubMed ID: 1838476
[TBL] [Abstract][Full Text] [Related]
55. A new approach to an influenza life vaccine: haemagglutinin cleavage site mutants generated by reverse genetics.
Stech J; Klenk HD
Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):186-91. PubMed ID: 16573209
[TBL] [Abstract][Full Text] [Related]
56. The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine.
Gabriel G; Garn H; Wegmann M; Renz H; Herwig A; Klenk HD; Stech J
Vaccine; 2008 Feb; 26(7):956-65. PubMed ID: 18164519
[TBL] [Abstract][Full Text] [Related]
57. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
[TBL] [Abstract][Full Text] [Related]
58. [Key role of Asp16 in proteolysis of influenza A NP protein by caspases in infected cells].
Zhirnov OP; Vorob'eva IV; Veselovskiĭ EM; Klenk N
Vopr Virusol; 2003; 48(6):8-14. PubMed ID: 14708223
[TBL] [Abstract][Full Text] [Related]
59. Intracellular oligomerization of influenza virus nucleoprotein.
Prokudina-Kantorovich EN; Semenova NP
Virology; 1996 Sep; 223(1):51-6. PubMed ID: 8806539
[TBL] [Abstract][Full Text] [Related]
60. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
Roberts PC; Lamb RA; Compans RW
Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
